United Kingdom

Evofem Biosciences Inc (EVFM.OQ)

EVFM.OQ on NASDAQ Stock Exchange Capital Market

17 May 2019
Change (% chg)

$0.58 (+11.55%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Evofem Biosciences Inc, formerly Neothetics, Inc., is a clinical-stage specialty biopharmaceutical company. The Company develops products to address unmet needs in women's sexual and reproductive health. The Company’s product Amphora, is a Multipurpose Vaginal pH Regulator (MVP-R) designed to regulate vaginal pH to within the... (more)


Beta: --
Market Cap(Mil.): $6.33
Shares Outstanding(Mil.): 13.83
Dividend: --
Yield (%): --


  EVFM.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -0.74 -- --
ROI: -80.14 14.23 13.82
ROE: -90.12 15.46 15.24

Evofem shares surge as contraceptive gel meets late-stage trial goal

Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel showed effectiveness in a late-stage study, bringing the first hormone-free contraceptive close to approval.

17 Dec 2018

UPDATE 3-Evofem shares surge as contraceptive gel meets late-stage trial goal

* Co to submit marketing application for gel in Q2 next year (Adds conference call comment, details on contraceptive market, updates shares)

17 Dec 2018

Evofem's hormone-free birth control gel meets main goal in key study

Dec 17 Evofem Biosciences Inc said on Monday its hormone-free birth control gel met the main goal in a late-stage study.

17 Dec 2018

Earnings vs. Estimates